Side-by-side comparison of AI visibility scores, market position, and capabilities
Lagos B2B pharmaceutical marketplace connecting 5,000+ African pharmacies to GSK/Pfizer/AstraZeneca with 24-hour delivery and inventory financing; $12M QED Investors Series A with 7x revenue growth.
Remedial Health is a Lagos-based B2B health technology company digitizing pharmaceutical procurement for African pharmacies and hospitals — operating an e-commerce marketplace connecting 5,000+ pharmacies and healthcare facilities with 300+ pharmaceutical manufacturers including GSK, Pfizer, and AstraZeneca, providing access to 8,000+ SKUs, 24-hour delivery across Nigeria, and inventory financing that enables pharmacies to stock products without full upfront capital. Founded in 2021 and backed with $16.4 million raised including a $12 million Series A led by QED Investors in March 2024, Remedial Health achieved 7x revenue growth in 10 months while tripling its client base since late 2023.
Dominant browser-based collaborative UI design platform at ~$600M ARR and $12.5B valuation; Adobe's $20B acquisition blocked by regulators in 2023, Figma remains independent competing with Sketch and Adobe.
Figma is a San Francisco-based collaborative web-based product design platform that has become the dominant tool for UI/UX designers and product teams — enabling real-time multi-user collaboration on interface design, prototyping, and design system management directly in the browser without installing desktop software. Founded in 2012 by Dylan Field and Evan Wallace and backed by Sequoia, Greylock, and Andreessen Horowitz with over $330 million raised, Figma generated approximately $600 million in ARR in 2023, serving 4 million+ designers and product teams at companies including Microsoft, Airbnb, Twitter, and Uber. Adobe announced a $20 billion acquisition offer in 2022, which was blocked by regulators in 2023 — Figma remains independent.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.